RICHARD B FRIED
CIK 1245637 · last filed 2022-01-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$227.60M
Companies
8
Total Filings
45
Lifetime Open-Market Net
$174.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HPP | Director | 1,114 | $14.75 | $16.4K | -$118.03M | 31 | 2022-01-03 |
| Playa Hotels & Resorts N.V. (PLYA) Delisted | Director | 40,918 | $13.48 | $551.6K | -$177.53M | 7 | 2021-11-15 |
| CLUB | 10%+ Owner | 0 | $24.88 | $0 | -$74.53M | 2 | 2017-06-20 |
| Nexvet Biopharma plc (NVET) Delisted | 10%+ Owner | 1,022,493 | — | — | $0 | 1 | 2015-02-11 |
| EPL OIL & GAS, INC. (EPL) Delisted | 10%+ Owner | 2,847,340 | — | — | -$48.00M | 1 | 2010-03-25 |
| HTH | 10%+ Owner | 5,951,369 | $38.24 | $227.58M | -$2.68M | 1 | 2008-09-22 |
| CAPITALSOURCE INC (CSE) Delisted | 10%+ Owner | 37,777,512 | — | — | $594.00M | 1 | 2008-07-01 |
| KNOLOGY INC (KNOL) Delisted | 10%+ Owner | 1,991,895 | — | — | $1.51M | 1 | 2007-10-17 |
Recent Filings · Page 4 of 5
45 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-13 | HPP | — | — | $0 | EDGAR |
| 2015-02-11 | Nexvet Biopharma plc (NVET) Delisted | Mixed | +74,999,880 | $140.00M | EDGAR |
| 2014-03-27 | HPP | — | — | $0 | EDGAR |
| 2013-05-21 | HPP | Grant (A) | +3,162 | $0 | EDGAR |
| 2012-06-11 | HPP | Grant (A) | +3,081 | $0 | EDGAR |
| 2012-05-22 | HPP | — | — | $0 | EDGAR |
| 2011-06-13 | HPP | Grant (A) | +3,281 | $0 | EDGAR |
| 2011-05-05 | HPP | — | — | $0 | EDGAR |
| 2011-01-24 | HPP | Grant (A) | +1,653 | $0 | EDGAR |
| 2010-07-01 | HPP | — | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.